Lv1
60 积分 2021-02-20 加入
Overall Survival After Allogeneic Transplantation in Advanced Cutaneous T-Cell Lymphomas (CUTALLO): A Propensity Score–Matched Controlled Prospective Study
12小时前
求助中
Carbimazole-induced acute myeloid leukemia: A very rare case report and review of the literature
4个月前
已关闭
Case Report: Extramedullary Hairy Cell Leukemia in Parotid Gland, Case Report and Review of the literature
4个月前
已关闭
Molecular monitoring versus standard clinical care in younger adults with acute myeloid leukaemia: results from the UK NCRI AML17 and AML19 randomised, controlled, phase 3 trials
5个月前
已完结
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial
5个月前
已关闭
Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma
5个月前
已完结
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
6个月前
已完结
Benefit with glofitamab plus chemotherapy in transplant-ineligible R/R DLBCL
7个月前
已完结
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
7个月前
已完结
Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia
7个月前
已完结
皖公网安备34019202002308
